Carboplatin is classified as a Platinum-based Drug.
Cisplatin is classified as a Platinum-based Drug. Cisplatin is more commonly known as the brand Platinol.
Dactinomycin is classified as an Actinomycin. Dactinomycin is more commonly known as the brand Cosmegen.
Etoposide is classified as a Topoisomerase Inhibitor. Etoposide, more commonly known as the brands Etopophos and Toposar, may be used to treat Bone Tissue Neoplasms.
Methotrexate is classified as a Folate Analog Metabolic Inhibitor. Methotrexate is included in 4 brands sold in the US including Otrexup, Rasuvo and Rheumatrex